The Effects of Prolonged Head-Down Tilt Lithotomy Position on Lower Limb Haemodynamics
NCT ID: NCT06036641
Last Updated: 2025-09-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
25 participants
OBSERVATIONAL
2024-07-22
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Prone Position on Liver Blood Flow and Function
NCT01781260
Hemodynamic Changes Due to Prone Position
NCT04491331
Hemodynamic Effects of Surgical Position in Prone vs. Supine Percutaneous Nephrolithotomy
NCT07138872
Intraoperative Haemodynamic Optimization Comparing Flow and Pressure Parameters
NCT02104687
Cardiac Output and Other Hemodynamic Changes With Prone Position in Cervical Myelopathy Patients Undergoing Surgery
NCT03027817
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aetiology of WLCS appears to be primarily related to ischaemia of the lower limbs after a prolonged period in the head-down tilt lithotomy (HDTL) position, which is commonly used to access the pelvis and perineum during urological, colorectal, and gynaecological surgery. Elevation of the lower limbs above the heart results in a \~2 mmHg drop in mean arterial pressure at the mid-calf for every 2.5 cm that the limbs are raised. These hemodynamic changes are accompanied by an increase in compartment pressures associated with limb elevation and are further exacerbated by a steep (\>15°) head-down tilt. The outcome of these changes ultimately leads to the development of significant and (often unrecognised) intraoperative ischemia in the lower limbs.
Prolonged reductions in lower limb perfusion during HDTL can cause the development of localised tissue oedema, leading to marked intracompartmental hypertension, which is further exacerbated once the limbs are lowered and reperfusion of ischemic muscle occurs. This is a consequence known as ischaemic-reperfusion injury (IRI), a phenomenon where reperfusion per se may result in a local and systemic inflammatory response that may augment tissue injury in excess of that produced by ischaemia alone.
Microvascular injury is considered one of the major determinants of IRI, particularly due to increased permeability of capillaries and arterioles that lead to an increase in diffusion and fluid filtration across the tissues. Subsequently, activated endothelial cells produce more reactive oxygen species and less nitric oxide, and this imbalance results in a corresponding inflammatory response and increased oxidative stress, which if sufficiently severe lead to further lower limb muscle and nerve injury.
The incidence of WLCS is unpredictable and as the individual is anaesthetised, the diagnosis is delayed in many cases, so the residual motor-sensory deficit may be severe, even after fasciotomy. Although there are many published case reports of this condition, it is likely that many cases of WLCS go unreported, and some may be mild and escape clinical detection. However, in cases that have been reported, the incidence of permanent disability after the development of WLCS ranges from ≈30% to ≈100%.
The paucity of detailed observational studies into the effects of HDTL on lower limb haemodynamics and tissue oxygenation has restricted the ability of the clinical and scientific society to construct clinical strategies to minimise this complication. Identifying individuals with risk factors and increasing surveillance during surgery in these people may allow for early detection and decrease the morbidity and potential mortality associated with intraoperative WLCS.
The study aims to assess lower limb haemodynamics by measuring cutaneous blood flow, muscle and brain tissue oxygenation, inflammatory and oxidative stress biomarkers during pelvic surgery in patients placed in HDTL. This study has the potential to provide a better understanding of the pathogenesis of WLCS and add novel knowledge regarding its early diagnosis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Colorectal surgery
Individuals scheduled for colorectal surgery in the HDTL position
NIRS monitoring
All participants will undergo NIRS monitoring of muscle and cerebral tissue oxygenation intraoperatively.
Laser Doppler flowmetry
Cutaneous blood flow will be assessed intraoperatively via Laser Doppler flowmetry in all participants
Inflammatory and Oxidative stress biomarkers
Blood samples will be taken to measure biomarkers of inflammation and oxidative stress at specific time points
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NIRS monitoring
All participants will undergo NIRS monitoring of muscle and cerebral tissue oxygenation intraoperatively.
Laser Doppler flowmetry
Cutaneous blood flow will be assessed intraoperatively via Laser Doppler flowmetry in all participants
Inflammatory and Oxidative stress biomarkers
Blood samples will be taken to measure biomarkers of inflammation and oxidative stress at specific time points
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Previous revascularisation procedure in their lower limbs
* BMI \> 40 kg/m2
* Inability to give informed consent
* Other serious medical conditions, which in the opinion of study investigators, would interfere with safety or data interpretation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Portsmouth Hospitals NHS Trust
OTHER_GOV
University of Portsmouth
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria Perissiou
Senior Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chukwuemeka C Uzoma, MBBS
Role: PRINCIPAL_INVESTIGATOR
University of Portsmouth
Maria C Perissiou, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Portsmouth
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queen Alexandra Hospital, Portsmouth Hospitals University NHS Trust
Portsmouth, West Sussex, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CPMS ID - 56254
Identifier Type: OTHER
Identifier Source: secondary_id
IRAS [287464]
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.